Sigilon Therapeutics

 

Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.

  • Chief Scientific Officer

Previous
Previous

Serotiny

Next
Next

Sonoma Biotherapeutics